Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 18, 2022 - Issue 3: Melanoma Immunotherapy
Submit an article Journal homepage
1,626
Views
3
CrossRef citations to date
0
Altmetric
Melanoma Immunotherapy SF – Research Paper

Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study

Ernesto Rossia Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, ItalyCorrespondence[email protected] [email protected]
ORCID Iconhttps://orcid.org/0000-0002-6442-1707View further author information
ORCID Icon,
Ilaria Grazia Zizzarib Laboratory of Tumor Immunology and Cell Therapy, Department of Experimental Medicine, Policlinico Umberto I, Sapienza University, Rome, ItalyCorrespondence[email protected]
View further author information
,
Alessandra Di Filippob Laboratory of Tumor Immunology and Cell Therapy, Department of Experimental Medicine, Policlinico Umberto I, Sapienza University, Rome, ItalyView further author information
,
Anna Acamporac Department of Life Sciences and Public Health, Università Cattolica del Sacro Cuore, Rome, ItalyView further author information
,
Monica Maria Pagliarad Ophtalmology, Fondazione Policlinico Universitario Agostino Gemelli, Rome, ItalyView further author information
,
Maria Grazia Sammarcod Ophtalmology, Fondazione Policlinico Universitario Agostino Gemelli, Rome, ItalyView further author information
,
Maurizio Simmacoe Spectrometry-Clinical Biochemistry Laboratory, Sant’Andrea University Hospital, Rome, ItalyView further author information
,
Luana Lionettoe Spectrometry-Clinical Biochemistry Laboratory, Sant’Andrea University Hospital, Rome, ItalyView further author information
,
Andrea Botticellif Medical Oncology, Policlinico Umberto I, Sapienza University, Rome, ItalyView further author information
,
Emilio Briaa Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy;g Medical Oncology, Università Cattolica del Sacro Cuore, Rome, ItalyView further author information
,
Paolo Marchettif Medical Oncology, Policlinico Umberto I, Sapienza University, Rome, ItalyView further author information
,
Maria Antonietta Blasid Ophtalmology, Fondazione Policlinico Universitario Agostino Gemelli, Rome, ItalyView further author information
,
Giampaolo Tortoraa Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy;g Medical Oncology, Università Cattolica del Sacro Cuore, Rome, ItalyView further author information
,
Giovanni Schinzaria Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy;g Medical Oncology, Università Cattolica del Sacro Cuore, Rome, ItalyView further author information
&
Marianna Nutib Laboratory of Tumor Immunology and Cell Therapy, Department of Experimental Medicine, Policlinico Umberto I, Sapienza University, Rome, ItalyView further author information
 show all
Article: 2034377 | Received 19 Sep 2021, Accepted 14 Dec 2021, Published online: 08 Mar 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.